Evidence map›Paper›PMID 36106104›Full record

ArticleFrontiers in oncology2022

GCLDNet: Gastric cancer lesion detection network combining level feature aggregation and attention feature fusion.

Xu Shi, Long Wang, Yu Li, Jian Wu, Hong Huang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Xu ShiKey Laboratory of Optoelectronic Technology and Systems of the Education Ministry of China, Chongqing University, Chongqing, China.
Long WangKey Laboratory of Optoelectronic Technology and Systems of the Education Ministry of China, Chongqing University, Chongqing, China.
Yu LiDepartment of Pathology, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing, China.
Jian WuHead and Neck Cancer Center, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing, China.
Hong HuangKey Laboratory of Optoelectronic Technology and Systems of the Education Ministry of China, Chongqing University, Chongqing, China.
Chongqing University of Technology · CNChongqing Cancer Hospital · CNChongqing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Analysis of histopathological slices of gastric cancer is the gold standard for diagnosing gastric cancer, while manual identification is time-consuming and highly relies on the experience of pathologists. Artificial intelligence methods, particularly deep learning, can assist pathologists in finding cancerous tissues and realizing automated detection. However, due to the variety of shapes and sizes of gastric cancer lesions, as well as many interfering factors, GCHIs have a high level of complexity and difficulty in accurately finding the lesion region. Traditional deep learning methods cannot effectively extract discriminative features because of their simple decoding method so they cannot detect lesions accurately, and there is less research dedicated to detecting gastric cancer lesions. Methods: We propose a gastric cancer lesion detection network (GCLDNet). At first, GCLDNet designs a level feature aggregation structure in decoder, which can effectively fuse deep and shallow features of GCHIs. Second, an attention feature fusion module is introduced to accurately locate the lesion area, which merges attention features of different scales and obtains rich discriminative information focusing on lesion. Finally, focal Tversky loss (FTL) is employed as a loss function to depress false-negative predictions and mine difficult samples. Results: Experimental results on two GCHI datasets of SEED and BOT show that DSCs of the GCLDNet are 0.8265 and 0.8991, ACCs are 0.8827 and 0.8949, JIs are 0.7092 and 0.8182, and PREs are 0.7820 and 0.8763, respectively. Conclusions: Experimental results demonstrate the effectiveness of GCLDNet in the detection of gastric cancer lesions. Compared with other state-of-the-art (SOTA) detection methods, the GCLDNet obtains a more satisfactory performance. This research can provide good auxiliary support for pathologists in clinical diagnosis.

Indexed as

artificial intelligenceattention feature fusionconvolutional neural networkdeep learninggastric cancer lesion detectionimage segmentationlevel feature aggregation

Identifiers

PMID36106104
PMCPMC9464831
OpenAlexW4293663012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.